Case Report: Re-Sensitization to Gefitinib in Lung Adenocarcinoma Harboring EGFR Mutation and High PD-L1 Expression After Immunotherapy Resistance, Which Finally Transform Into Small Cell Carcinoma

The treatment sequence of immunotherapy (IO) and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is of great importance for the survival of non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutation. Here, we reported an advanced lung adenocarcinoma case concu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Xiaoqian, Liu, Jiewei, Liang, Zuoyu, Li, Zhixi, Liu, Yanyang, Huang, Lin, Wang, Weiya, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264361/
https://www.ncbi.nlm.nih.gov/pubmed/34249697
http://dx.doi.org/10.3389/fonc.2021.661034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264361/
https://www.ncbi.nlm.nih.gov/pubmed/34249697
http://dx.doi.org/10.3389/fonc.2021.661034

Ejemplares similares